Journal of Cardiothoracic and Vascular Anesthesia
Volume 21, Issue 4 , Pages 519-523 , August 2007

Differential Expression in Markers for Thrombin, Platelet Activation, and Inflammation in Cell Saver Versus Systemic Blood in Patients Undergoing On-Pump Coronary Artery Bypass Graft Surgery

  • Hiroo Takayama, MD
    • ,
  • Louise O. Soltow, BS
    • ,
  • Gabriel S. Aldea, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Gabriel S. Aldea, MD, Department of Surgery, Cardiothoracic Division AA-115, University of Washington, Box 356310, 1959 NE Pacific Street, Seattle, WA 98195-3166.

References 

  1. Borowiec JW, Bozdayi M, Jaramillo A, et al. Influence of two blood conservation techniques (cardiotomy reservoir versus cell-saver) on biocompatibility of the heparin-coated cardiopulmonary bypass circuit during coronary revascularization surgery. J Card Surg. 1997;12:190–197
  2. Aldea GS, Soltow LO, Chandler WL, et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg. 2002;123:742–755
  3. Lindholm L, Westerberg M, Bengtsson A, et al. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients. Ann Thorac Surg. 2004;78:2131–2138
  4. Westerberg M, Bengtsson A, Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg. 2004;78:54–59
  5. Videm V, Svennevig JL, Fosse E, et al. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg. 1992;103:806–813
  6. Pekna M, Hagman L, Halden E, et al. Complement activation during cardiopulmonary bypass: Effects of immobilized heparin. Ann Thorac Surg. 1994;58:421–424
  7. Fosse E, Moen O, Johnson E, et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 1994;58:472–477
  8. Ovrum E, Mollnes TE, Fosse E, et al. High and low heparin dose with heparin-coated cardiopulmonary bypass: Activation of complement and granulocytes. Ann Thorac Surg. 1995;60:1755–1761
  9. Aldea GS, Doursounian M, O’Gara P, et al. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: A prospective, randomized study. Ann Thorac Surg. 1996;62:410–417
  10. Aldea GS, O’Gara P, Shapira OM, et al. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Ann Thorac Surg. 1998;65:425–433
  11. Spiess BD, Vocelka C, Cochran RP, et al. Heparin-coated bypass circuits (Carmeda) suppress the release of tissue plasminogen activator during normothermic coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 1998;12:299–304
  12. Greilich PE, Brouse CF, Whitten CW, et al. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: A randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin. J Thorac Cardiovasc Surg. 2003;126:1498–1503
  13. Corcoran TB, Engel A, Sakamoto H, et al. The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 2004;18:592–604
  14. Bourbon A, Vionnet M, Leprince P, et al. The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response. Eur J Cardiothorac Surg. 2004;26:932–938
  15. Brooker RF, Brown WR, Moody DM, et al. Cardiotomy suction: A major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg. 1998;65:1651–1655
  16. Anderson RE, Hansson LO, Liska J, et al. The effect of cardiotomy suction on the brain injury marker S100beta after cardiopulmonary bypass. Ann Thorac Surg. 2000;69:847–850
  17. Philippou H, Adami A, Davidson SJ, et al. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. Thromb Haemost. 2000;84:124–128
  18. Svenmarker S, Engstrom KG. The inflammatory response to recycled pericardial suction blood and the influence of cell-saving. Scand Cardiovasc J. 2003;37:158–164
  19. Spanier T, Tector K, Schwartz G, et al. Endotoxin in pooled pericardial blood contributes to the systemic inflammatory response during cardiac surgery. Perfusion. 2000;15:427–431
  20. Reents W, Babin-Ebell J, Misoph MR, et al. Influence of different autotransfusion devices on the quality of salvaged blood. Ann Thorac Surg. 1999;68:58–62
  21. Kincaid EH, Jones TJ, Stump DA, et al. Processing scavenged blood with a cell saver reduces cerebral lipid microembolization. Ann Thorac Surg. 2000;70:1296–1300
  22. Kaza AK, Cope JT, Fiser SM, et al. Elimination of fat microemboli during cardiopulmonary bypass. Ann Thorac Surg. 2003;75:555–559
  23. Amand T, Pincemail J, Blaffart F, et al. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit. Perfusion. 2002;17:117–123
  24. Jewell AE, Akowuah EF, Suvarna SK, et al. A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery. Eur J Cardiothorac Surg. 2003;23:633–636
  25. Serrick CJ, Scholz M, Melo A, et al. Quality of red blood cells using autotransfusion devices: A comparative analysis. J Extra Corpor Technol. 2003;35:28–34
  26. Ishida K, Gohara T, Kawata R, et al. Are serum S100beta proteins and neuron-specific enolase predictors of cerebral damage in cardiovascular surgery?. J Cardiothorac Vasc Anesth. 2003;17:4–9
  27. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989;84:1045–1049
  28. Smith WB, Gamble JR, Clark-Lewis I, et al. Interleukin-8 induces neutrophil transendothelial migration. Immunology. 1991;72:65–72
  29. Franke A, Lante W, Fackeldey V, et al. Pro-inflammatory cytokines after different kinds of cardiothoracic surgical procedures: Is what we see what we know?. Eur J Cardiothorac Surg. 2005;28:569–575
  30. Matsuzaki K, Hiramatsu Y, Homma S, et al. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation. Ann Thorac Surg. 2005;80:611–617
  31. Sablotzki A, Friedrich I, Muhling J, et al. The systemic inflammatory response syndrome following cardiac surgery: Different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions. Perfusion. 2002;17:103–109
  32. Devaney JM, Greene CM, Taggart CC, et al. Neutrophil elastase upregulates interleukin-8 via toll-like receptor 4. FEBS Lett. 2003;544:129–132
  33. Johnsson P, Blomquist S, Luhrs C, et al. Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. Ann Thorac Surg. 2000;69:750–754
  34. Grocott HP, Croughwell ND, Amory DW, et al. Cerebral emboli and serum S100beta during cardiac operations. Ann Thorac Surg. 1998;65:1645–1649
  35. Jonsson H, Johnsson P, Alling C, et al. S100beta after coronary artery surgery: Release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg. 1999;68:2202–2208
  36. Anderson RE, Hansson LO, Nilsson O, et al. Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. Ann Thorac Surg. 2001;71:1512–1517

 Supported in part by grants from Medtronic Perfusion Systems, Minneapolis, MN.

PII: S1053-0770(07)00030-4

doi: 10.1053/j.jvca.2007.01.020

Journal of Cardiothoracic and Vascular Anesthesia
Volume 21, Issue 4 , Pages 519-523 , August 2007

Article Tools

* Image Usage & Resolution